Markus Jerling
Directeur Technique/Scientifique/R&D chez ONCOZENGE AB
Profil
Markus Jerling currently holds three positions as Chief Medical Officer at Kancera AB, OncoZenge AB, and Chief Medical & Business Officer at Diamyd Medical AB.
Previously, he worked as Director-Drug Safety at Pharmacia Corp., Vice President-Clinical Research at CV Therapeutics, Inc., and Chief Medical Officer at Newron Sweden AB.
He also worked as a Principal at Astra Arcus AB.
Dr. Jerling received a doctorate degree from Karolinska Institutet.
Postes actifs de Markus Jerling
| Sociétés | Poste | Début |
|---|---|---|
| ONCOZENGE AB | Directeur Technique/Scientifique/R&D | 01/05/2021 |
| KANCERA AB | Directeur Technique/Scientifique/R&D | 01/09/2023 |
| DIAMYD MEDICAL AB | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Markus Jerling
| Sociétés | Poste | Fin |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/01/2000 |
| Astra Arcus AB | Corporate Officer/Principal | 01/01/1998 |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Directeur Technique/Scientifique/R&D | - |
Formation de Markus Jerling
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ONCOZENGE AB | Health Technology |
| KANCERA AB | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| Astra Arcus AB |
